InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,723.77
(
-1.55%
)
US TECH 100
19,441.20
(
-2.09%
)
Dow Jones
41,919.11
(
-0.53%
)
Brent Oil
72.57
(
-0.08%
)
Bitcoin
70,507.80
(
-2.53%
)
Post# of 4982869
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

beerput

Send PM Follow Ignore
Followers 72
Posts 9917
Boards Moderated 0
Alias Born 09/05/2009

beerput

Re: None

Wednesday, 10/22/2014 7:31:11 PM

Wednesday, October 22, 2014 7:31:11 PM

Post# of 4982869
IBIO on the WHO’s list for the trial candidates(EBOLA)>
Mapp Biopharmaceuticals’ experimental Ebola drug ZMapp is perhaps the most advanced drug to date, and is also on the WHO’s list for the trial candidates. However, supplies of the drug have been exhausted. The company is currently looking for different ways to increase production, one of which is collaboration with Caliber Biotherapeutics and Ibio Inc (IBIO)
http://www.bidnessetc.com/27717-tekmira-gains-on-new-ebola-drug-update/2/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up